Jakobs noted that these major long-term agreements involve hundreds of millions of dollars. "Some of these deals are volatile.
They are of very large size — contracts of hundreds of millions or millions of dollars, over multiple years — and therefore you cannot pinpoint exactly when they will be finalized," said Jakobs.
Analysts from RBC pointed out that lower demand and operational headwinds in China weighed heavily on second-quarter sales growth.
China implemented a policy in July requiring all public medical institutions to purchase equipment through centralized procurement programs, creating market disruption.
"We have seen that this has caused a kind of market disruption and contraction," said Jakobs.
The company confirmed it had already factored these ongoing challenges into its financial planning.
>>> US Halts Strikes on Iran as Trump Cites Ongoing Talks
"We foresee a structurally more challenging situation in China, which we had taken into account," said Jakobs.
